ScholarIQanswers from OpenAlex & ORCID
Kensei Yamaguchi
ResearcherPublications, citations & collaboration network
Kensei Yamaguchi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kensei Yamaguchi have?
ScholarIQindexed works
Kensei Yamaguchi has 925 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kensei Yamaguchi have?
ScholarIQcitation count
Kensei Yamaguchi has 23,012 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kensei Yamaguchi?
ScholarIQh-index
Kensei Yamaguchi has an h-index of 67 in OpenAlex.
What is the i10-index of Kensei Yamaguchi?
ScholarIQi10-index
Kensei Yamaguchi has an i10-index of 288 in OpenAlex.
What is the ORCID of Kensei Yamaguchi?
ScholarIQorcid
The ORCID for Kensei Yamaguchi is on the source record.
What is the OpenAlex record for Kensei Yamaguchi?
ScholarIQopenalex
The OpenAlex for Kensei Yamaguchi is on the source record.
What are the most-cited papers on Kensei Yamaguchi?
ScholarIQmost cited works
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
Yasuhide Yamada, Katsuhiko Higuchi, Kazuhiro Nishikawa, M. Gotoh, Nozomu Fuse, Naotoshi Sugimoto, Tomohiro Nishina, Kenji Amagai, Keisho Chìn, Y. Niwa, Akihito Tsuji, Hiroshi Imamura, Masahiro Tsuda, Hirofumi Yasui, Hirofumi Fujii, Kensei Yamaguchi, Hisateru Yasui, Shuichi Hironaka, Keiji Shimada, Hiroto Miwa, Chieko Hamada, Ichinosuke Hyodo
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda, Hideaki Bando, Ken Kato, Chigusa Morizane, Taito Esaki, Yoshito Komatsu, Yasuyuki Kawamoto, Naoki Takahashi, Makoto Ueno, Yoshinori Kagawa, Tomohiro Nishina, Takeshi Kato, Yoshiyuki Yamamoto, Junji Furuse, Tadamichi Denda, Hisato Kawakami, Eiji Oki, Takako Eguchi Nakajima, Naohiro Nishida, Kensei Yamaguchi, Hisateru Yasui, Masahiro Goto, Nobuhisa Matsuhashi, Koushiro Ohtsubo, Kentaro Yamazaki, Akihito Tsuji, Wataru Okamoto, Katsuya Tsuchihara, Takeharu Yamanaka, Miki Izumi, Yasutoshi Sakamoto, Hiroko Ichiki, Masayuki Hata, Riu Yamashita, Atsushi Ohtsu, Justin I. Odegaard, Takayuki Yoshino
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
Narikazu Boku, Min‐Hee Ryu, Ken Kato, Hyun Cheol Chung, Keiko Minashi, K.-W. Lee, H. Cho, Won Ki Kang, Yoshito Komatsu, Masahiro Tsuda, Kensei Yamaguchi, Hiroki Hara, Soichi Fumita, Mizutomo Azuma, L.-T. Chen, Yoon‐Koo Kang